Compare AU
Compare NNWH vs. DRUG
Compare shares and ETFs on the ASX that you can trade on Pearler.
Overview
When it comes to investing in the Australian stock market, shares and ETFs are a popular choice. Two options in the ASX are NNWH and DRUG. In this comparison, we'll delve into these options across various dimensions to help you make an informed investment decision.
Community Stats
NNWH | DRUG | |
|---|---|---|
Popularity | Low | Low |
Pearlers invested | 1 | 65 |
Median incremental investment | $996.75 | $990.50 |
Median investment frequency | Weekly | Monthly |
Median total investment | $3,543.75 | $1,955.77 |
Average age group | > 35 | 26 - 35 |
Key Summary
NNWH | DRUG | |
|---|---|---|
Strategy | NNWH.AX was created on 2023-05-30 by Nanuk. The fund's investment portfolio concentrates primarily on total market equity. The Funds performance objective is to provide investment returns which exceed conventional global equity indices, after management fees, over the long term. | DRUG.AX was created on 2016-08-04 by BetaShares. The fund's investment portfolio concentrates primarily on health care equity. DRUG.AX aims to track the performance of an index (before fees and expenses) that comprises the largest global healthcare companies (ex-Australia), hedged into Australian dollars. |
Top 3 holdings | Nanuk New World Fund (Currency Hedged) Active ETF (100 %) | BRL - BRAZILIAN REAL (0 %) AUD - AUSTRALIA DOLLAR (0 %) CHF - SWISS FRANC (0 %) |
Top 3 industries | Other (76.17 %) Communication Services (33.53 %) Health Care (23.66 %) | |
Top 3 countries | United States (71.71 %) Switzerland (8.14 %) Denmark (6.30 %) | |
Management fee | 0 % | 0.57 % |
Key Summary
NNWH | DRUG | |
|---|---|---|
Issuer | Nanuk | BetaShares |
Tracking index | Nasdaq Global ex-Australia Healthcare Hedged AUD Index - AUD | |
Asset class | ETF | ETF |
Management fee | 0 % | 0.57 % |
Price | $1.125 | $7.61 |
Size | N/A | $169.381 million |
10Y return | N/A | N/A |
Annual dividend/ distribution yield (5Y) | - % | 1.89 % |
Market | ASX | ASX |
First listed date | 29/09/2024 | 08/08/2016 |
Purchase fee | $6.50 | $6.50 |
Community Stats
NNWH | DRUG | |
|---|---|---|
Popularity | Low | Low |
Pearlers invested | 1 | 65 |
Median incremental investment | $996.75 | $990.50 |
Median investment frequency | Weekly | Monthly |
Median total investment | $3,543.75 | $1,955.77 |
Average age group | > 35 | 26 - 35 |
Pros and Cons
NNWH | DRUG | |
|---|---|---|
Pros |
|
|
Cons |
|
|
NNWH | DRUG |
|---|---|
Lower exposure to US market | Higher exposure to US market |
Lower management fee | Higher management fee |
Lower price growth | Higher price growth |
Lower distribution yield | Higher distribution yield |